These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26057409)

  • 1. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
    Scheinfeld N
    Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apraclonidine in the treatment of ptosis.
    Wijemanne S; Vijayakumar D; Jankovic J
    J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ptosis as a complication of botulinum toxin injection.
    Omoigui S; Irene S
    Pain Med; 2005; 6(2):149-51. PubMed ID: 15773880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GaAs laser treatment of bilateral eyelid ptosis due to complication of botulinum toxin type A injection.
    Majlesi G
    Photomed Laser Surg; 2008 Oct; 26(5):507-9. PubMed ID: 18922092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
    Bernardini FP; Skippen B; Croasdell B; Cerón Bohórquez JM; Murray G; Sayed K; Walker L; Hartstein ME;
    Aesthet Surg J; 2023 Aug; 43(9):955-961. PubMed ID: 36943792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
    Nestor MS; Han H; Gade A; Fischer D; Saban Y; Polselli R
    J Cosmet Dermatol; 2021 Oct; 20(10):3133-3146. PubMed ID: 34378298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 0.5% apraclonidine solution in evaluation of blepharoptosis.
    Yazici B; Beden U
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):299-301. PubMed ID: 18645436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin injection for production of ptosis].
    Merté RL; Lanzl IM
    Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable ptosis after botulinum toxin type a injection with positive ice test mimicking ocular myasthenia gravis.
    Alaraj AM; Oystreck DT; Bosley TM
    J Neuroophthalmol; 2013 Jun; 33(2):169-71. PubMed ID: 23681240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.
    Sung J; Song A; Song M; Song J
    J Med Case Rep; 2022 Aug; 16(1):299. PubMed ID: 35927744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
    Ghalamkarpour F; Aghazadeh Y; Odabaei G
    J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
    Carruthers J
    Aesthet Surg J; 2023 Aug; 43(9):962-963. PubMed ID: 36978211
    [No Abstract]   [Full Text] [Related]  

  • 16. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
    Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
    Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution.
    Labadie JG; Dover JS
    J Am Acad Dermatol; 2024 Jun; 90(6):1311-1312. PubMed ID: 38151056
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper Eyelid Response to Topical 0.5% Apraclonidine.
    Kirkpatrick CA; Shriver EM; Clark TJE; Kardon RH
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):13-19. PubMed ID: 27984360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.